Impact AI

I will be taking a brief hiatus for the next three months. I’m going to be using this time to step back, reflect, and rework the format of the show to bring you even more valuable insights and engagi…

What role can artificial intelligence play in detecting breast cancer earlier, when it's most treatable? In this episode of Impact AI, we hear from Nico Karssemeijer, Chief Science Officer of ScreenP…

How can we harness medical imaging and artificial intelligence to shift healthcare from reactive to predictive? In this episode, I sit down with Ángel Alberich-Bayarri to discuss how artificial intel…

Drug development is notoriously time-consuming and expensive, but what if we could simulate clinical trials before they even begin? Orr Inbar, Co-Founder and CEO of QuantHealth, joins me to explore h…

The recent destruction of the Pacific Palisades in Los Angeles was a brutal reminder of why we need robust early wildfire detection systems. Joining me today is Shahab Bahrami, the co-founder and CTO…

AI is transforming drug discovery by making biological data more accessible and actionable, bridging the gap between complex sequencing data and real-world therapeutic breakthroughs. As Rick Schneide…

AI tools for healthcare are becoming more prevalent than ever before, and today, we explore how this could help usher in a future of democratized healthcare for all. I am joined by the neurocritical …

Radiologists face a growing demand for imaging analysis, yet existing AI tools remain fragmented, each solving only a small part of the workflow. Today, we continue our series on domain-specific foun…

What if a routine endoscopy could do more than just detect disease by actually predicting treatment outcomes and revolutionizing precision medicine? In this episode of Impact AI, Matt Schwartz, CEO a…

Zelda Mariet, Co-Founder and Principal Research Scientist at Bioptimus, joins me to continue our series of conversations on the vast possibilities and diverse applications of foundation models. Today…

What if the hidden patterns of time series data could be unlocked to predict the future with remarkable accuracy? In this episode of Impact AI, I sit down with Max Mergenthaler Canseco to discuss dem…

In this episode, I'm joined by Ron Alfa, Co-Founder and CEO of Noetik, to discuss the groundbreaking role of foundation models in advancing cancer immunotherapy. Together, we explore why these models…

How can foundation models accelerate breakthroughs in precision medicine? In today’s episode of Impact AI, we explore this question with returning guest, Julianna Ianni, Vice President of AI Research…

With farmers sometimes waiting weeks for lab results to make critical decisions, Benjamin De Leener, Co-Founder and Chief Science Officer of ChrysaLabs, sought to transform the future of soil health.…

Can AI cure autoimmune diseases? This episode of Impact AI dives into the groundbreaking work of DeepCure, where artificial intelligence meets medicinal chemistry to tackle some of healthcare's most …

What if we could unlock the hidden potential of unstructured health data to improve patient outcomes? In this episode, I sit down with David Sontag, co-founder and CEO of Layer Health, to discuss the…

How can advancements in biotechnology and machine learning lead to revolutionary treatments for age-related diseases? In this episode, I speak with Hanadie Yousef, CEO and Co-Founder of Juvena Therap…

To succeed at an AI startup, you have to be able to show your work and its value. During this episode, I am joined by Brigham Hyde, Co-Founder and CEO of Atropos Health, to talk about his app that ga…

As machine learning becomes increasingly widespread, AI holds the potential to revolutionize drug development, making it faster, safer, and more affordable than ever. In this episode, I'm joined by J…

Today’s guest believes that decoding the immune system is at the heart of improving drug efficacy. He is currently focused on this effort as the CEO and Co-founder of Immunai – a company that is buil…